Clinical Data to Help Quintiles Study Long-QT | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data today said it will use its diagnostic technologies to help Quintiles Transnational study drug-induced QT prolongation, the company said today.
 
Clinical Data said it will offer several services that focus on the potential genetic causes of QT prolongation and to help Quintiles with regulatory guidelines.
 
Long-QT is contributes to delays in drug development and drug withdrawals.
 
Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.